DGX
NYSE · Health Care
Quest Diagnostics Inc
$193.58
-1.42 (-0.73%)
Financial Highlights (FY 2026)
Revenue
10.81B
Net Income
971.78M
Gross Margin
33.3%
Profit Margin
9.0%
Rev Growth
+3.7%
D/E Ratio
0.82
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 33.3% | 33.3% | 50.2% | 50.2% |
| Operating Margin | 14.1% | 12.7% | 20.1% | 18.0% |
| Profit Margin | 9.0% | 8.5% | 17.8% | 16.0% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 10.81B | 10.42B | 4.96B | 4.20B |
| Gross Profit | 3.60B | 3.47B | 2.49B | 2.11B |
| Operating Income | 1.52B | 1.32B | 999.46M | 755.35M |
| Net Income | 971.78M | 843.07M | 884.89M | 672.43M |
| Gross Margin | 33.3% | 33.3% | 50.2% | 50.2% |
| Operating Margin | 14.1% | 12.7% | 20.1% | 18.0% |
| Profit Margin | 9.0% | 8.5% | 17.8% | 16.0% |
| Rev Growth | +3.7% | +3.7% | -4.8% | +13.2% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 4.86B | 4.86B | 7.82B | 8.74B |
| Total Equity | 5.93B | 5.93B | 17.06B | 17.56B |
| D/E Ratio | 0.82 | 0.82 | 0.46 | 0.50 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 1.68B | 1.53B | 1.34B | 1.22B |
| Free Cash Flow | — | — | 654.29M | 513.32M |